Morgan Stanley’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.51M Buy
1,718,875
+17,890
+1% +$84.5K ﹤0.01% 3811
2025
Q4
$8.59M Buy
1,700,985
+237,844
+16% +$1.1M ﹤0.01% 3734
2025
Q3
$5.08M Buy
1,463,141
+313,020
+27% +$1.18M ﹤0.01% 4133
2025
Q2
$3.91M Buy
1,150,121
+404,644
+54% +$1.35M ﹤0.01% 4256
2025
Q1
$2.99M Sell
745,477
-343,984
-32% -$1.78M ﹤0.01% 4324
2024
Q4
$7.07M Buy
1,089,461
+22,403
+2% +$133K ﹤0.01% 3689
2024
Q3
$5.91M Buy
1,067,058
+172,694
+19% +$979K ﹤0.01% 3842
2024
Q2
$4.99M Buy
894,364
+50,843
+6% +$305K ﹤0.01% 3876
2024
Q1
$5.66M Sell
843,521
-828,791
-50% -$6.56M ﹤0.01% 3821
2023
Q4
$15.3M Buy
1,672,312
+1,058,019
+172% +$6.66M ﹤0.01% 3582
2023
Q3
$3.39M Buy
614,293
+43,997
+8% +$353K ﹤0.01% 4014
2023
Q2
$4.87M Buy
570,296
+53,332
+10% +$478K ﹤0.01% 3793
2023
Q1
$4.75M Buy
516,964
+327,379
+173% +$3.52M ﹤0.01% 3828
2022
Q4
$1.94M Sell
189,585
-25,457
-12% -$342K ﹤0.01% 4492
2022
Q3
$3.17M Buy
215,042
+18,399
+9% +$239K ﹤0.01% 4062
2022
Q2
$2.11M Buy
196,643
+78,756
+67% +$784K ﹤0.01% 4495
2022
Q1
$1.27M Buy
117,887
+112,808
+2,221% +$1.52M ﹤0.01% 4831
2021
Q4
$82K Sell
5,079
-35,836
-88% -$750K ﹤0.01% 6551
2021
Q3
$875K Buy
+40,915
New +$962K ﹤0.01% 5134

Other funds holding CTKB